{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:57:27Z","timestamp":1789999047230,"version":"4.0.1"},"reference-count":23,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0019-5154.92668","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T12:10:34Z","timestamp":1328530234000},"page":"12","source":"Crossref","is-referenced-by-count":77,"title":["Serum concentration of IL-6, IL-2, TNF-\u03b1, and IFN\u03b3 in Vitiligo patients"],"prefix":"10.4103","volume":"57","author":[{"given":"Suman","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SS","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0019-5154.92668-1","first-page":"285","volume-title":"Vitiligo","author":"Lerner","year":"1959","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.92668-2","first-page":"90","volume-title":"Evidence for an autoimmune pathogenesis of vitiligo","author":"Ongenae","year":"2003","journal-title":"Pigment cell Res"},{"key":"key-10.4103\/0019-5154.92668-3","first-page":"1061","volume-title":"Autoimmune melanocyte destruction in vitiligo","author":"van","year":"2001","journal-title":"Lab Invest"},{"key":"key-10.4103\/0019-5154.92668-4","first-page":"208","volume-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","author":"Alkahateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0019-5154.92668-5","first-page":"221","volume-title":"Possible pathogenetic relevance of interleukin-1\u00e2 in \u2032destructive\u2032 organ-specific autoimmune disease (Hashimoto\u2032s thyroiditis)","author":"Paolieri","year":"1999","journal-title":"Ann New York Acad Sci"},{"key":"key-10.4103\/0019-5154.92668-6","first-page":"703","volume-title":"Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment","author":"Espersen","year":"1993","journal-title":"APMIS"},{"key":"key-10.4103\/0019-5154.92668-7","first-page":"329","volume-title":"Interleukin-8","author":"Ko","year":"1995","journal-title":"Rinsho Byori"},{"key":"key-10.4103\/0019-5154.92668-8","first-page":"523","volume-title":"Intrathyroidal cytokine gene expression in Hashimoto\u2032s thyroiditis","author":"Ajjan","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/0019-5154.92668-9","first-page":"87","volume-title":"New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0019-5154.92668-10","first-page":"337","volume-title":"Lymphocyte imbalance in vitiligo patients indicated by elevated CD4C\/CD8C T-cell ratio","author":"Pichler","year":"2009","journal-title":"Wien Med Wochenschr"},{"key":"key-10.4103\/0019-5154.92668-11","first-page":"527","volume-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo","author":"Yu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.92668-12","first-page":"799","volume-title":"Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment","author":"Zailaie","year":"2005","journal-title":"Saudi Med J"},{"key":"key-10.4103\/0019-5154.92668-13","first-page":"320","volume-title":"Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: Evidence for a regulatory role of IL-6, IL-7, TNF-\u00e1 and UVB light","author":"Kirnbauer","year":"1992","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.92668-14","first-page":"191","volume-title":"Influence of inflammatory mediators and cytokines on human melanocyte function","author":"Morelli","year":"1993","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.92668-15","first-page":"287","volume-title":"Depletion and repopulation of Langerhans cells in non-segmental type vitiligo","author":"Kao","year":"1990","journal-title":"J Dermatol"},{"key":"key-10.4103\/0019-5154.92668-16","first-page":"849","volume-title":"Keratinocyte dysfunction in vitiligo epidermis: Cytokine microenvironment and correlation to keratinocyte apoptosis","author":"Moretti","year":"2009","journal-title":"Histol Histopathol"},{"key":"key-10.4103\/0019-5154.92668-17","first-page":"683","volume-title":"Immunopolarization of CD4 + and Cd8+T cells to type-1-like is associated with melanocyte loss in human vitiligo","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"key":"key-10.4103\/0019-5154.92668-18","first-page":"961","volume-title":"The main function of IL-2 is to promote the development of T regulatory cells","author":"Malek","year":"2003","journal-title":"J Leukoc Biol"},{"key":"key-10.4103\/0019-5154.92668-19","first-page":"182","volume-title":"Serum concentration of the soluble interleukin-2 receptor in vitiligo patients","author":"Yeo","year":"1999","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0019-5154.92668-20","first-page":"109","volume-title":"Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE","author":"Galadari","year":"2005","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"key-10.4103\/0019-5154.92668-21","unstructured":"Goldsmith MA, Greene WC. Interleukin-2 and the interleukin-2 receptor. In: Thomson A, editor. The Cytokine Handbook, 2 nd ed. London: Academic Press; 1994. p. 55-80"},{"key":"key-10.4103\/0019-5154.92668-22","first-page":"91","volume-title":"Interleukin-2 and the interleukin-2 receptor complex","author":"Gaulton","year":"1994","journal-title":"Chem Immunol"},{"key":"key-10.4103\/0019-5154.92668-23","first-page":"619","volume-title":"The soluble interleukin-2 receptor: Biology, function, and clinical application","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T15:47:35Z","timestamp":1392997655000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.e-ijd.org\/text.asp?2012\/57\/1\/12\/92668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"alternative-id":["92668"],"URL":"https:\/\/doi.org\/10.4103\/0019-5154.92668","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}